Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 200

1.

Mechanisms and Treatment Progress of Rituximab-Resistance in Diffuse Large B-cell Lymphoma.

Yang L, Zou L, Gu S, Kong L, Sun S, Song G, Cho WC.

Curr Cancer Drug Targets. 2019 Jan 26. doi: 10.2174/1568009619666190126125251. [Epub ahead of print]

PMID:
31142246
2.

Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients.

de Fraipont F, Gazzeri S, Cho WC, Eymin B.

Front Genet. 2019 May 7;10:390. doi: 10.3389/fgene.2019.00390. eCollection 2019. Review.

3.

Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b.

Vu LT, Peng B, Zhang DX, Ma V, Mathey-Andrews CA, Lam CK, Kiomourtzis T, Jin J, McReynolds L, Huang L, Grimson A, Cho WC, Lieberman J, Le MT.

J Extracell Vesicles. 2019 Apr 14;8(1):1599680. doi: 10.1080/20013078.2019.1599680. eCollection 2019.

4.

Wnt Signaling: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma

Javed Z, Muhammad Farooq H, Ullah M, Zaheer Iqbal M, Raza Q, Sadia H, Pezzani R, Salehi B, Sharifi-Rad J, Cho WC.

Asian Pac J Cancer Prev. 2019 Apr 29;20(4):995-1003.

5.

Pharmacodynamic monitoring using biomarkers to individualize pharmacotherapy.

Theile D, Cho WC.

Biomark Med. 2019 Apr;13(5):393-408. doi: 10.2217/bmm-2018-0355. Epub 2019 Mar 29.

PMID:
30924677
6.

Chemoresistance mechanisms of breast cancer and their countermeasures.

Ji X, Lu Y, Tian H, Meng X, Wei M, Cho WC.

Biomed Pharmacother. 2019 Jun;114:108800. doi: 10.1016/j.biopha.2019.108800. Epub 2019 Mar 25. Review.

7.

Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein-Barr virus (EBV).

Ali A, Khan A, Kaushik AC, Wang Y, Ali SS, Junaid M, Saleem S, Cho WCS, Mao X, Wei DQ.

Sci Rep. 2019 Jan 24;9(1):720. doi: 10.1038/s41598-018-37070-z.

8.

Efficacy and safety of Chinese herbal medicine for patients with postmenopausal hypertension: A systematic review and meta-analysis.

Xiong X, Yang X, Li X, Yue G, Xing Y, Cho WC.

Pharmacol Res. 2019 Mar;141:481-500. doi: 10.1016/j.phrs.2019.01.018. Epub 2019 Jan 11. Review.

PMID:
30639372
9.

A systematic review of herbal medicines for the treatment of cancer cachexia in animal models.

Park B, You S, Cho WCS, Choi JY, Lee MS.

J Zhejiang Univ Sci B. 2019 Jan.;20(1):9-22. doi: 10.1631/jzus.B1800171. Review.

10.

The rise of human stem cell-derived natural killer cells for cancer immunotherapy.

Wang K, Han Y, Cho WC, Zhu H.

Expert Opin Biol Ther. 2018 Dec 24:1-8. doi: 10.1080/14712598.2019.1559293. [Epub ahead of print]

PMID:
30583701
11.

Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer.

Cho WCS, Tan KT, Ma VWS, Li JYC, Ngan RKC, Cheuk W, Yip TTC, Yang YT, Chen SJ.

Oncotarget. 2018 Nov 20;9(91):36344-36357. doi: 10.18632/oncotarget.26349. eCollection 2018 Nov 20.

12.

The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.

Wu M, Tong CWS, Yan W, To KKW, Cho WCS.

Curr Cancer Drug Targets. 2019;19(5):382-399. doi: 10.2174/1568009618666181031145953.

PMID:
30381077
13.

Multi-scale representation of proteomic data exhibits distinct microRNA regulatory modules in non-smoking female patients with lung adenocarcinoma.

Chan LW, Wang F, Meng F, Wang L, Wong SCC, Au JS, Yang S, Cho WC.

Comput Biol Med. 2018 Nov 1;102:51-56. doi: 10.1016/j.compbiomed.2018.09.005. Epub 2018 Sep 12.

PMID:
30245277
14.

Clinical efficacy of acupoint embedment in weight control: A systematic review and meta-analysis.

Cho WC, Li C, Chen HY.

Medicine (Baltimore). 2018 Sep;97(36):e12267. doi: 10.1097/MD.0000000000012267. Review.

15.

Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.

Selvaraj G, Kaliamurthi S, Kaushik AC, Khan A, Wei YK, Cho WC, Gu K, Wei DQ.

J Biomed Inform. 2018 Oct;86:120-134. doi: 10.1016/j.jbi.2018.09.004. Epub 2018 Sep 6.

PMID:
30195659
16.

Turning point for cancer management.

Cho WCS, Au JSK.

Ann Transl Med. 2018 Jul;6(14):281. doi: 10.21037/atm.2018.06.41. No abstract available.

17.

Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine.

Oeyen E, Van Mol K, Baggerman G, Willems H, Boonen K, Rolfo C, Pauwels P, Jacobs A, Schildermans K, Cho WC, Mertens I.

J Extracell Vesicles. 2018 Jul 3;7(1):1490143. doi: 10.1080/20013078.2018.1490143. eCollection 2018.

18.

Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer.

Vychytilova-Faltejskova P, Stitkovcova K, Radova L, Sachlova M, Kosarova Z, Slaba K, Kala Z, Svoboda M, Kiss I, Vyzula R, Cho WC, Slaby O.

Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1019-1028. doi: 10.1158/1055-9965.EPI-18-0318. Epub 2018 Jul 5.

PMID:
29976566
19.

Recent Advances in the Treatment of Breast Cancer.

Tong CWS, Wu M, Cho WCS, To KKW.

Front Oncol. 2018 Jun 14;8:227. doi: 10.3389/fonc.2018.00227. eCollection 2018. Review.

20.

Efficient RNA drug delivery using red blood cell extracellular vesicles.

Usman WM, Pham TC, Kwok YY, Vu LT, Ma V, Peng B, Chan YS, Wei L, Chin SM, Azad A, He AB, Leung AYH, Yang M, Shyh-Chang N, Cho WC, Shi J, Le MTN.

Nat Commun. 2018 Jun 15;9(1):2359. doi: 10.1038/s41467-018-04791-8.

Supplemental Content

Loading ...
Support Center